Bio-Techne Corp
TECH
Market Cap$7.59B
Close$
$37.35
25.1% downside
Current Fair Value
25.1% downsideOvervalued by 25.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.59 Billion |
|---|---|
| Enterprise Value | $7.91 Billion |
| Dividend Yield | $0.32 (0.661157024793389%) |
| Earnings per Share | $1.07 |
| Beta | 1.46 |
| Outstanding Shares | 157,372,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 57.85 |
|---|---|
| PEG | -107.21 |
| Price to Sales | 7.12 |
| Price to Book Ratio | 4.15 |
| Enterprise Value to Revenue | 6.54 |
| Enterprise Value to EBIT | 46 |
| Enterprise Value to Net Income | 60 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Bio-Techne Corp
2,100 employees
CEO: Charles Kummeth Bio-Techne Corporation is a holding company for biotechnology and clinical diagnostic brands. It was founded in 1976 as Techne Corporation and changed its name to Bio-Techne in 2014. The company's brands include flagship R&D Systems , No...